Ivana Mikolasevic
Overview
Explore the profile of Ivana Mikolasevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1093
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vucinic D, Redzovic A, Hauser G, Mikolasevic I
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002939
Radiotherapy (RT) is one of the major cornerstones in managing gastrointestinal (GI) cancers. However, several side effects, such as intestinal inflammation, mucosal injury, and dysbiosis, often compromise this. The gut...
2.
Petrc A, Salopek T, Skocilic I, Zahirovic D, Orlic L, Bubic I, et al.
Case Rep Oncol
. 2025 Feb;
18(1):7-14.
PMID: 39980524
Introduction: Melanoma often metastasizes to the liver, leading to significant morbidity and mortality. Liver injury can also occur due to hepatitis caused by immunotherapy used in the treatment of melanoma....
3.
Grgurevic I, Filipec Kanizaj T, Ivekovic H, Mikolasevic I, Milic S, Mrzljak A, et al.
Acta Clin Croat
. 2025 Feb;
63(1):214-243.
PMID: 39959335
Liver diseases are currently the eleventh leading cause of global mortality, and cirrhosis holds the ninth position among the causes of death in Europe. The progression of cirrhosis gives rise...
4.
Rados L, Golcic M, Mikolasevic I
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857680
The intestinal microbiota is an important part of the human body, and its composition can affect the effectiveness of immunotherapy. In the last few years, the modulation of intestinal microbiota...
5.
Oguic R, Grskovic A, Spanjol J, Mikolasevic I, Djordjevic G
Medicina (Kaunas)
. 2025 Jan;
60(12.
PMID: 39768912
: Prostate cancer is one of the most commonly diagnosed cancers in the male population and the fifth leading cause of cancer death worldwide in men as of 2022. One...
6.
Skocilic I, Golcic M, Petrc A, Kolak M, Kolovrat D, Ropac S, et al.
J Pers Med
. 2024 Sep;
14(9).
PMID: 39338149
Background: There are limited real-world data (RWD) regarding the use of cyclin-dependent kinase (CDK) 4/6 inhibitors in western Balkan. The aim of our study was thus to analyze factors influencing...
7.
Vucinic D, Skocilic I, Golcic M, Dobrila-Dintinjana R, Kolak M, Jerkovic I, et al.
J Pers Med
. 2024 Mar;
14(3).
PMID: 38541020
Background: The development of immunotherapy checkpoint inhibitors (ICIs) has revolutionized cancer care. However, old patients are underrepresented in most clinical trials, although they represent a significant proportion of real-world patients....
8.
Marinovic S, Lenartic M, Mladenic K, Sestan M, Kavazovic I, Benic A, et al.
Sci Immunol
. 2023 Sep;
8(87):eadd1599.
PMID: 37774007
Metabolic-associated fatty liver disease (MAFLD) is a spectrum of clinical manifestations ranging from benign steatosis to cirrhosis. A key event in the pathophysiology of MAFLD is the development of nonalcoholic...
9.
Bozic D, Grgurevic I, Mamic B, capkun V, Bilandzic-Ivisic J, Ivanovic T, et al.
Nutrients
. 2023 Aug;
15(15).
PMID: 37571273
Bioelectrical impedance analysis (BIA) is a body composition assessment method. We aimed to determine its accuracy in the detection of sarcopenia in patients with liver cirrhosis (LC), using skeletal muscle...
10.
Puljiz Z, Kumric M, Vrdoljak J, Martinovic D, Kurir T, Krnic M, et al.
Nutrients
. 2023 May;
15(10).
PMID: 37242119
Obesity is a disorder identified by an inappropriate increase in weight in relation to height and is considered by many international health institutions to be a major pandemic of the...